Literature DB >> 1730565

An inhibitor of tumor cell growth from normal horse serum.

K K Ericson1, T J Yang.   

Abstract

During our studies of cytostatic cytokines in the mixed leukocyte culture, we found that horse serum in the medium control contained a tumor cell growth-inhibitory factor. The fraction isolated by molecular sieving and ion exchange chromatography inhibited the growth and DNA synthesis of the primary culture and passaged cell line of the canine transmissible venereal sarcoma, murine T (L5178Y) and B (P3-X63-Ag8.653) lymphoid tumor cells, murine mammary tumor cells (RIII), bovine lymphoid tumor cells (BL3), and the nontransformed cell line of baby hamster kidney cells. Nontransformed cell lines such as African green monkey kidney (Vero) and Madin-Darby bovine kidney cells and normal mammary cells of the dog and goat were inhibited only at high concentrations. The active component is a protein with an Rf value of 0.09 upon electrophoresis in native 7.5% polyacrylamide gels. The eluate from the native gel could be further separated into three polypeptides with molecular weights of approximately 67, 65, and 55 kDa under reduced conditions in sodium dodecyl sulfate-polyacrylamide gels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730565     DOI: 10.1007/bf02631074

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  10 in total

1.  Cytostatic activity of dialyzed SDS-page eluates.

Authors:  K K Ericson; T J Yang
Journal:  In Vitro Cell Dev Biol       Date:  1992-01

2.  The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line.

Authors:  M Kobayashi; J M Plunkett; I K Masunaka; R S Yamamoto; G A Granger
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

3.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.

Authors:  M D O'Connor-McCourt; L M Wakefield
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

4.  Fetal bovine serum alternatives.

Authors:  D W Jayme; D A Epstein; D R Conrad
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

5.  Molecular and biological characterization of anticarcinogenic and tumor cell growth-inhibitory activities of Syrian hamster lymphotoxin.

Authors:  J H Ransom; C H Evans
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

6.  A selective inhibitor of cell proliferation from normal serum.

Authors:  W N Harrington; G C Godman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

7.  Change in the ploidy state of rat liver cells during chemical hepatocarcinogenesis and its relationship to the increased expression of alpha-fetoprotein.

Authors:  R J Scott; S Chakraborty; S Sell; J M Hunt; H A Dunsford
Journal:  Cancer Res       Date:  1989-11-01       Impact factor: 12.701

8.  Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells.

Authors:  P R Ervin; M S Kaminski; R L Cody; M S Wicha
Journal:  Science       Date:  1989-06-30       Impact factor: 47.728

9.  Lymphocyte response to phytohemagglutinin: temporal variation in normal dogs.

Authors:  K Angus; T J Yang
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

10.  Identification and physicochemical characterization of a tumor-associated antigen from canine transmissible venereal sarcoma.

Authors:  T J Palker; T J Yang
Journal:  J Natl Cancer Inst       Date:  1981-04       Impact factor: 13.506

  10 in total
  1 in total

1.  Growth modulation of human tumor cells by a growth-inhibiting activity derived from tumorigenic V79 Chinese hamster cells.

Authors:  I Ichinose; S Nakano; T Esaki; T Koga; K Mitsugi; H Yamada; Y Niho
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.